The thymidine kinase induced in lytic infection by each of 36 intertypic recombinants of herpes simplex virus (HSV) type I and type 2 was identified as type I or type 2 by studies on the thermolability of enzyme activity, neutralization with type I or type 2 antiserum and agar gel immunodiffusion with type I or type 2 thymidine kinase antiserum. Fourteen recombinants induced no thymidine kinase, I2 induced type I thymidine kinase and io induced type 2 thymidine kinase. Correlation of these results with restriction endonuclease analysis of the DNA of the recombinants with five restriction endonucleases (XbaI, EcoRI, HpaI, HsuI, and BgIII) allowed mapping of the type i thymidine kinase gene at o'3oo to o'3o9 map unit and the type 2 thymidine kinase gene at o-295 to o'315 map unit.
INTRODUCTION
Enzymic, immunological and physical studies indicate that herpes simplex virus type I (HSV-I) and herpes simplex virus type 2 (HSV-2) induce a new thymidine kinase in lytic infections (Klemperer et aL 1967 ; Thouless & Skinner, 197 I) . This enzyme possesses deoxycytidine kinase and thymidylate kinase activities in addition to thymidine kinase I974; Chen& Prusoff, I978 ) . It can be differentiated from cellular thymidine kinase by several biochemical criteria including mobility on polyacrylamide gel electrophoresis (PAGE), substrate requirement, thermolability (Munyon et aL I972; Kit et aL I974; Kit, I976) , reaction with HSV-specific antiserum (Honess & Watson, I974a ) and neutralization by HSV-specific antiserum (Klemperer et al. I967 ). It appears from the serological results to be virus coded, since virus mutants have been isolated which are unable to induce this enzyme activity (Dubbs & Kit, i964; Buchan et aL I97o; Jamieson et al. I974) or which synthesize incomplete polypeptides of the enzyme (Summers et al. I975) .
The enzyme induced by HSV-I differs in a number of respects from that induced by HSV-2 infection. The HSV-I thymidiue kinase polypeptide is slightly larger than that of HSV-2 Thouless & Wildy, I975) and is more thermostable at 4o °C (Ogino & Rapp, I97t ; Thouless & Skinner, I97r) . Antiserum to HSV-I-infected RK I3 cells neutralizes HSV-I thymidine kinase activity and antiserum to HSV-2-infected cells neutralizes the type 2 enzyme activity (Thouless, I972) . There is some intertypic neutralizing activity with these antisera, suggesting some common antigenic determinants, but much greater intratypic activity, suggesting that the enzymes bear type-specific determinants and allowing differentiation of the two enzymes by serological methods.
In recent years, increasing interest has been drawn to this enzyme as a marker for studies of transformation of mammalian cells lacking the enzyme, either by infecting cells with virus inactivated with u.v. light (Munyon et al. 197 I) or by inoculating cells with fragments of virus DNA (Bachetti & Graham, 1977; Maitland & McDougall, 1977; Wiglet et al. 1977; Minson et al. 1978 ) .
In this paper, we report on the physical location of the parental DNA sequences specifying the structural genes of the thymidine kinases of HSV-1 and HSV-2 by analysis of intertypic recombinants of HSV-I and HSV-2 (Halliburton et al. 1977; Morse et al. 1977) . First, the thymidine kinase induced by the recombinants was identified as type I or type 2 by studies of the thermolability of enzyme activity and by serological methods and second, physical maps of the DNA of the recombinants were obtained by restriction endonuclease analysis. Correlation of the two sets of results then allowed the position of the genes coding for type I and type 2 thymidine kinase to be determined.
METHODS
Cells and media. BHK 2I cells and RK 13 cells were grown in 8o oz. roller bottles in Eagle's medium (Autopow, Glasgow modification autoclavable powder; Flow Laboratories, Irvine, Scotland) supplemented with lO °/o (v/v) tryptose phosphate broth and 5 % (v/v) calf serum (BHK 21) or 5 % (v/v) rabbit serum (RK I3). Veto cells were grown in Eagle's minimal essential medium supplemented with IO % calf serum, o.ooi % ferric nitrate and I ~o sodium pyruvate.
Viruses. The viruses used in this study were: (I) HSV-I, strain HFEM (Watson et al. 1966) ; (z) HSV-I, strain STH2, a low passage stock of HFEM; (3) HSV-I, strain B2oo6, a thymidine kinase-deficient mutant isolated from strain PDK by Dubbs & Kit (1964) ; (4) HSV-2, strain 3345 (Sire & Watson, 1973) ; (5) HSV-2, strain 186 (RaMs et al. 1968) ; (6) HSV-2, strain Bry TK-, a thymidine kinase-deficient mutant isolated from strain Bry by Thouless (I972) ; (7) ts LSI, ts LB2, ts LB5 and ts LB 7, ts mutants of HFEM (Halliburton et al. I977); (8) HSV-I and HSV-2 intertypic recombinants A8E, CID, C2D, C4D, C5D, C6D, DIE4, DIE5, D3EI, D4E2, D4E 3, D5EI and D5E2 isolated by Morse et al. (1977) . Virus stocks were prepared by infecting ceils at low multiplicity (o-oi p.f.u./cell). All stocks were grown in BHK cells with the exception of C4 D and C6D which give about Ioo-fold higher yield in Veto cells. Plaque titrations were performed in BHK cells by the suspension assay of Russell (i962) using an overlay medium containing carboxymethylcellulose.
Isolation ofintertypic recombinants. Recombinants used in this study [other than those isolated by Morse et aL (1977) described above] are listed in Table 2 . All were isolated by plaque purification from mixed infections with a ts mutant of HSV-I strain HFEM (ts LSI, ts LB2, ts LB 5 or ts LB7) and the wild-type HSV-2, 3345 as described by Halliburton et al. (1977) .
Recombinant nomenclature. In the nomenclature adopted for recombinants isolated in Leeds (Table 2) all recombinants have the initial letter R for recombinant followed by a letter and a number from the type Its mutant used as a parental virus in their isolation (S indicates that the mutant was a spontaneous mutant isolated in the absence of added mutagen and B indicates that the mutant was isolated from 5-bromodeoxyuridine (BrdUrd)-mutagenized stock) followed by the clone number (I, 2, etc.). Thus, recombinants RB70 and RB% were derived from crosses between ts LB 7 and 3345. RB7o was the progeny of the first plaque picked and RB% the progeny of the seventh plaque picked under selective conditions from that cross. All recombinants were plaque purified at least three times, incu-HSV thymidine kinase 237 bation being at the non-permissive temperature of 38.5 °C (Halliburton et al. 1977) . Recombinants RB20 and RB5o were previously referred to as RB2 and RB5, respectively (Halliburton et al. I977) . The recombinants isolated in Chicago are identified by initial letters A, C, or D. The A series were isolated from mixed infections involving tsJ of strain I7 (HSV-0 and GP6 (HSV-z), the C series from ts NIo2 of strain STHz (HSV-I) × 186 (HSV-2) and the D series from ts E6 of strain KOS (HSV-I)× 186 (HSV-2) as described by Morse et al. 0977) .
Antisera. General antisera to RK I3 cells infected with type I (HFEM) or type 2 (3345) virus were prepared as described previously (Watson et al. I966) by repeated immunization of rabbits with extracts of infected RK 13 cells.
Type I and type 2 TK antisera were obtained by serum absorption. Thus, to obtain type I TK antiserum, lO 9 BHK cells were infected with strain B2oo6 at an input multiplicity of about lO p.f.u./cell. After 2o h, the cells were harvested, disrupted by ultrasonic oscillation and mixed with I ml of type 1 antiserum (HFEM). The mixture was left overnight at 4 °C, clarified by centrifugation at Iooooo g for 60 min and the supernatant fluid concentrated to ~ ml by vacuum dialysis. The type 2 TK antiserum was obtained in an analogous manner by absorbing type 2 (3345) antiserum with strain Bry TK-infected cells.
Thymidine kinase assays. BHK cells were infected at an input multiplicity of about Io p.f.u./cell, at 37 °C for I5 h, washed in phosphate-buffered saline and resuspended in sterile distilled water at IOs cells/ml. The suspension was disrupted by ultrasonic oscillation, centrifuged at IOOOOO g for I h and the supernatant fluid used as the source of crude enzyme for the TK assay. Protein content was determined by the method of Lowry et al. (I95I) . The activity was assayed using 2-14C-thymidine (sp. act. 53 mCi/mmol, The Radiochemical Centre, Amersham). The standard reaction mixture contained: 14C-thymidine, lOO#M; ATP, 20 mM; MgClz, 25 mM; 0"2 M-sodium phosphate buffer, pH 6-0; 4o#1 cell extract containing 5, 2o or 40 #g protein and water to a total vol. of o.2I ml in conical centrifuge tubes. The mixtures were incubated at 37 °C for lO min, placed in a boiling water bath for 2"5 min and centrifuged at 2ooo g for lO min to remove denatured protein. Volumes (50 #l) of the supernatant fluids were spotted on to DEAE-cellulose paper, washed in I raMammonium formate, dried and counted in a liquid scintillation analyser.
Thymidine kinase neutralization. Samples (o.t ml) of antiserum or pre-immune serum were mixed with o. r ml of cell extract, diluted so that controls gave about 2000o ct/min/assay. After Io min at 4 °C, 4o/zl of the mixture was assayed for thymidine kinase activity.
Thymidine kinase thermolability. Samples of cell extract (5 and 2o #g protein) in thin glass-walled vials were placed in a water bath at 4I"5 °C for I5 min and then immediately assayed for thymidine kinase activity.
Preparation of infected cell antigen and agar gel immunodiffusion. BHK cells were infected with wild-type virus or an intertypic recombinant at a m.o.i, of about Io. Cells were harvested after 2o h at 37 °C, washed with PBS, resuspended in distilled water at lO s cells/ml and disrupted by ultrasonic oscillation. Immunodiffusion tests were performed in 3 mm thick layers of agar (~ % lonagar, Oxoid, Basingstoke, Hants, U.K.) using an array of wells which allowed reactions between antigen at 1/I dilution with antiserum at dilutions of 1/I to I/27 to be observed on the same plate as reactions of undiluted antiserum, with dilutions of antigen varying from I/I to I/27 (Honess et al. 1974) .
Isolation of virus DNA. Vero cells were infected and labelled and the virus DNA extracted as described by Morse et al. (I977) .
Restriction endonuclease digestion. The DNA was cleaved with EcoRI, BgllI, HpaI HsuI and XbaI and the resulting fragments separated by electrophoresis through tubes (I x 20 cm) containing 0"4% agarose (Seakem, Marine Colloids Inc., Rockland, Md., U.S.A.) as described by Morse et al. (t977) . 
Isolation of intertypie recombinants
One spontaneous mutant (ts LSI) and three isolated in the presence of BrdUrd (ts LB2, -5 and -7) from HSV-I strain HFEM were used in mixed infections with HSV-2 strain 3345 in the isolation of intertypic recombinants. The efficiency of plating at 38"5 and 34 °C for these viruses is shown in Table I which also shows that HFEM and the four ts mutants each give plaques with a syncytial morphology (syn) whereas 3345 produces plaques with a nonsyncytial morphology (syn+). In Table I the virus DNA phenotype of the ts mutant is defined as the ability to synthesize virus DNA at the non-permissive temperature compared with the ability of the wild-type virus to synthesize virus DNA at this temperature. Ts LSI is DNA positive, ts LB2 and ts LB5 are +_, meaning that they each synthesize less than 2o % of the DNA produced by the wild-type virus and ts LB7 produces no detectable virus DNA at this temperature. The DNA phenotype for ts LB5 was previously reported as positive (Schaffer et al. I978) The four series of new intertypic recombinants analysed in these studies were prepared by infecting cells with the viruses containing the markers shown in Table 2 . The doubly infected BHK cells were incubated at 38"5 °C for T8 h, the progeny being plated under carboxymethylcellulose overlay at 38"5 °C. Recombinants were isolated by picking syn plaques, isolates of the initial cross being repeatedly plaque purified (three to six times) at non-permissive temperatures before stocks were prepared.
Biological properties of recombinants
The recombinants isolated in this study are listed in Table z. All recombinants produce plaques with a syncytial morphology with the exception of RB53. RB51 was isolated from a mixed infection between ts LB 5 and 3345 but even after five plaque purifications the resulting stock virus showed a mixture of syn and syn + plaques. The virus was plaque purified a sixth time and a syn (RB50 and syn + (RB53) plaque morphology recombinant was selected. These two recombinants are, therefore, clonally related. Serial passages of RB53 at low or at high multiplicities yield a syn + virus whereas serial passage of RB51 yields, after two passages, virus with an increasing proportion of syn + plaques. It is likely, therefore, that RB5z arises from RB5x as a result of a mutation occurring at a high frequency.
Table z also shows the efficiency of plating at 38"5 and 34 °C. All recombinants have ratios of plating efficiencies characteristic of the wild-type viruses (Table I) .
TK phenotype of parent viruses
The levels of TK activity in cells infected with wild-type viruses HFEM and 3345 and ts mutants of HFEM were assayed at the permissive (34 °C) and non-permissive (38"5 °C) temperatures.. Routinely, dilutions of cell extract containing 5, zo and 4 ° jug protein were assayed for enzyme activity. The wild-type-infected BHK showed little variability at the different temperatures used in this assay (Table 3 ) and roughly proportional increases in activity were found with increasing amounts of protein assayed up to a maximum of about 4oooo ct/min/assay. The activity of type 2 TK is reproducibly greater than that of type I TK on a concentration basis (Table 4 ).
The ts mutant LSI induces approximately wild-type TK activities and thus the genome does not contain mutations that affect TK induction. Ts LB5 and ts LB 7 have little or no TK activity when grown at either the permissive or non-permissive temperatures. Therefore, they have a non-ts defect in the TK gene. Ts LB2-infected cells have approximately normal TK activity when grown at the permissive temperature and little or none at the nonpermissive temperature, thus a ts mutation must be present in a gene involved with thymidine kinase induction.
Subsequent analyses include some intertypic recombinants isolated in Chicago (Morse et al. 1977) . For the A series, the parental strains are ts J (HSV-I) which is TK + (Subak- Sharpe et al. 1975 ) and GP6 (HSV-2), which is also TK + (Table 4) . For the C series, the parental strains are ts NIo2 (HSV-I) which is TK + (A. Buchan, personal communication) and 186 (HSV-2) which is also TK + (Table 4) . For D series, the parental viruses are ts E6 (HSV-I) which fails to induce TK activity at permissive or non-permissive temperatures (Aron et al. I973) and ts B 5 (HSV-2) which is TK + (Esparza et al. 1974) . Therefore, since ts LB5, ts LB 7 and ts E6 fail to induce TK activity at either temperatures, it is possible that some of the intertypic recombinants isolated from crosses involving these ts mutants may also be TK-.
Identification of recomb&ants specifying TK
Viruses were screened for induction of TK activity in two ways: first by titration in the presence and absence of BrdUrd and second by assaying for TK activity. Table 4 shows the results obtained with these two approaches with three type t (plus STH2) and four type 2 strains. HFEM, STH2, PDK, 3345, 186, GP6 and Bry all gave yields in the presence of BrdUrd I. I to 2"7 % of that obtained in the absence of the drug, showing that they possessed TK capable of phosphorylating BrdUrd. B2oo6 and Bry TK-, on the other hand, gave corresponding figures of 88. 4 and 8o'5 %, showing that they failed to induce TK activity. These findings were confirmed by the direct assay for TK activity in infected cell extracts (Table 4) .
Of the 36 intertypic recombinants studied, 22 gave yields in the presence of BrdUrd between o.I and o.6% of that obtained in its absence and, therefore, specify TK (Table 5) . Ten intertypic recombinants (RSI3, RB50, RB70, RB71, RB73, RB7n, RB%, RB77, D5EI and D5E2 gave yields in the presence of BrdUrd between 65"3 and 9I"3 % of that obtained in its absence and, therefore, probably do not specify TK. The four remaining recombinants reproducibly gave corresponding yields of I5"8% (RB5O, 3o'o% (D4E3), 31"5% 241 (D4E2) and 32.I ~o (D3EI) and it is, therefore, difficult to specify their TK phenotype although they probably specify reduced amounts of TK. These conclusions were largely confirmed by direct assay of induced TK activity (Table 5 )-Of the 22 recombinants giving greatly reduced titres in the presence of BrdUrd, ~ 8 showed TK activity comparable to the parental wild-type viruses (Table 4) , four (RB29, C4 D, C5D and C6D) showed reduced levels of activity but each of these recombinants grows less well than the other viruses in BHK cells. Of the l o recombinants that grow almost as well in the presence as in the absence of BrdUrd, none of them shows enzyme activity significantly increasing above background with increased amounts of cell extract assayed. Of the four recombinants showing intermediate titres in the presence of BrdUrd, three (D3EI, D4E2 and D4E3) show no assayable thymidine kinase activity and the fourth (RBs~) shows only very low levels of activity.
Typing of thymidine kinase specified by recombinants
The thymidine kinase specified by the recombinants was typed as HSV-~ or HSV-2 by studies on the neutralization of enzyme activity with type [ or type 2 antiserum, by studies on the thermolability of enzyme activity and by geldiffusion with thymidine kinase antiserum. I. W. HALLIBURTON AND OTHERS 
Neutralization of enzyme activity with type I or type 2 antiserum
Thymidine kinase neutralization tests were done on two type I and two type 2 wild-type viruses and on the 22 thymidine kinase-positive intertypic recombinants (Table 6 ). The type I antiserum (anti-HFEM) reduced the activities of type I strain preparations (HFEM and PDK) by 79"2 to 88% and those of type 2 strain preparations (3345 and I86) by 9"8 to I6.2 %. The type 2 antiserum (anti-3345) behaved reciprocally, reducing the enzyme activity of type 2 strains by 73 to 97"4% and those of type I strains by I8.2 to 26%.
The thymidine kinase activity of I2 of the recombinants was reduced by 7I % or more by type t antiserum and 26.6 % or less by type 2 antiserum. The thymidine kinase specified by these recombinants (RSI0, RSI1, RSI 2, RSI4, RB23, RB2s, RB29, RB2,0, RB211, C4D, C5D and C6D) is, therefore, typed as type I. The enzyme activity of the remaining Io recombinants was reduced by 74"5 % or more by type 2 antiserum and by 34"5 % or less by type I antiserum. The thymidine kinase specified by these recombinants (RB20, RB25, RB51, RB53, RB74, A8E, CID, C2D, DIE4, DIE5) is therefore typed as type 2.
Thermolability of enzyme activity
Thymidine kinase activity was assayed either immediately or following pre-incubation at 4o °C for io min. more of their activity following the pre-incubation whereas type 2 strains (3345 and ~86) had lost 83"5 ~o or more of their activity. As shown by Thouless & Skinner (I97x) , therefore, type r thymidine kinase is appreciably more thermostable than type z. The activity of the thymidine kinase specified by ~ I of the recombinants was reduced by 24"2 ~o or less by the pre-incubation. These recombinants (RSr 0, RSrl, RSr2, RSt4, RB23, RB28, RB29, RB210, RBzn, C5D and C6D) therefore specify a type I-like thymidine kinase. The activity of the thymidine kinase of to of the recombinants was reduced by 96.I % or more by the pre-incubation. These recombinants (RB20, RB25, RB51, RB53, RB74, A8E, CID, CzD, DIE4 and DIE5) therefore specify a type 2-like thymidine kinase. The remaining recombinant, C4D, shows intermediate residual activity of 43"I % which does not allow unambiguous typing of its thymidine kinase.
Gel diffusion with thymidine kinase antiserum
Type ~ thymidine kinase antiserum was prepared by absorbing type ~ antiserum (anti-HFEM) with an excess of extracts of cells infected with HSV-I strain B2oo6, a thymidine kinase deficient strain (Dubbs & Kit, ~964;  Table 4 ). In gel diffusion, this antiserum gave only one precipitin line against a sonicate of cells infected with HFEM and none against cells infected with B2oo6 or type 2 virus. A corresponding type 2 thymidine kinase antiserum was prepared by absorbing type 2 antiserum (anti-3345) with an excess of extracts of cells infected with HSV-2 strain Bry TK-. Sonicates of cells infected with Ia recombinants gave one precipitin line with type ~ thymidine kinase antiserum, I ~ gave one precipitin line with type 2 thymidine kinase antiserum and I3 gave no precipitin lines with either antiserum (Table 7) . No recombinant gave precipitin lines with type I and type 2 antiserum, i.e. no recombinant gave evidence of specifying both a type I and a type 2 thymidine kinase.
Restriction endonuclease mapping of crossover points in the recombinants
In order to map the position of the genes coding for type I and type 2 thymidine kinase it is necessary to determine the amount of type ~ and type 2 DNA possessed by the recombinants and to map the position of the sites of recombinational events. This has been done for the A, C and D group recombinants used in this paper by restriction endonuclease analysis of their DNA (Morse et al. ~977) . The crossover points in the other recombinants were determined precisely as described by Morse et al. (I977) 
Restriction endonuclease analysis of parental virus strains HFEM and 3345
Since the parental strains of the other recombinants used in this work differ from those of the A, C and D group recombinants (with the probable exception that the type I parental strain of the C group recombinants is STH2 from which the HFEM used was derived by I.W. HALLIBURTON AND OTHERS further passage in tissue culture) it was first necessary to establish the restriction endonuclease maps of HFEM and 3345. These are described relative to the Chicago prototype strains HSV-r (F) and HSV-2 (G) ( The analysis of the DNA of one of the recombinants, RB5 o, is given in detail to indicate the way in which the position of the crossover points was determined. Fig. r shows the autoradiograms of electrophoretically separated asP-labelled DNA fragments of recombinant and parental strains. The analysis depended on determining which recombinant DNA fragments co-migrated with type I or type 2 parental fragments. When such fragments were identified, it was assumed that the recombinant DNA possessed the cleavage sites limiting that fragment. When new fragments, corresponding to those of neither parent, were identified it was assumed that they possessed both type I and type 2 DNA and therefore contained the crossover points. The boundaries of the crossover points were set independently for each enzyme. The maximum and minimum positions of the crossover regions can then be set by analysis of the combined restriction endonuclease maps. The maximum boundaries were determined by the map positions of type x and type 2 cleavage sites positively identified as being in the recombinant DNA. The minimum boundaries in some instances could be inferred from the absence of cleavage sites that are present in one of the parental DNAs between the positively identified cleavage sites. Fig. I shows autoradiograms of RB5o 32P-DNA digested with XbaI, HsuI, BgllI, EcoRI and HpaI. Digestion of RB50 DNA with XbaI generated several fragments that co-migrated with HSV-2 fragments. Specifically, fragments D, GH, GI, G, H, I and J were present in appropriate molar ratios as indicated by band intensities. There is no fragment as large as the o'25 M fragment CH of type z but there are clearly new fragments larger than D but smaller than CH of type 2. Since the 0"5 M fragments H and I of type 2 are present, this means that the o'5 M fragment C is missing. A unique fragment with an approx, mol. wt. of ~5"o × lO e has appeared, together with something of approx. 30 x io 6. The smaller of these is most probably most of fragment F of type I. There are, therefore, two crossovers: one between the HSV-2, C, D and HSV-I C, F sites and one between the HSV-~ C, F and GC sites.
Analysis of the DNA of recomb&ant RB 5 o
Digestion of recombinant DNA with HsuI generated fragments that co-migrated with the HSV-2, A, IK, JK, E, IM, JM, I, J, K, L and M fragments. There are two fragments comparable to the A and B fragments of HSV-2 but the RB50 fragments differ in size more than the 3345 fragments because the RB5o 'B fragment' is smaller. There is, therefore, a crossover between HSV-I J, A and I, J sites. There is also a unique fragment with an approx. mol. wt. of I4. 5 x I@ which must be part of HSV-I A fragment. There is, therefore, a second crossover between HSV-I J, A sites and HSV-2 H, E sites. This leaves only one unique fragment of approx, mol. wt. 6"9 x io 6 which is part of the HSV-2 G fragment. There is, therefore, a crossover between HSV-I N, M sites and HSV-2 P, G sites and a second crossover between HSV-I M, I sites and HSV-2 G, J sites. An alternative interpretation of the data is that HSV-2 fragment J is missing and the fragment of mol. wt. 7-2 x IO n is part of HSV-I fragment I. In this case the second crossover would be between HSV-t M, I sites and HSV-2 J, O sites. Digestion of the recombinant DNA with EcoRI generated HSV-2 fragments A, FK, HK, FM, HM, F, G, H, J, K, L, M, N and O and HSV-I N. There is some partially digested material with HSV-I and RB50 of mol. wt. greater than fragment A. There is also a unique fragment of approx, mol. wt. 7"5 x io 6. There is, therefore, one crossover between HSV-x G, N and HSV-z J, ] sites and a second crossover between HSV-I N, F and HSV-2 I, G sites.
Digestion of the recombinant DNA with HpaI generated HSV-z fragments FS, GS, F and G and HSV-I fragment I. There are, in addition, only two other unique fragments, one of approx, tool. wt. about t 9 x io n (which on this autoradiogram is very faint for unknown reasons) and one of greater than 3o × Io n mol. wt. Since there is clearly no fragment M of HSV-I there must be a crossover from HSV-I M, I sites to HSV-z, the 19 x IO 6 fragment being part of HSV-2 A. In addition, since there is no HSV-I fragment B, there must be a crossover to the right of HSV-r but whether this is at the HSV-I I, V or V, B boundary is not clear since fragment V runs with the dye front and is not visible on these gels. Similarly, the precise site of the crossover point in type 2 cannot be ascertained since it could either be at the A, H or H, D sites, fragment H being too small to be resolved. The fragment of mol. wt. greater than 3o × [06 can only arise by invoking two other crossovers since there is no type t or type 2 fragment of this size. The HSV-2 cleavage site between fragments D and E cannot be present and so there must be a crossover on either side of this cleavage site but the amount of HSV-I DNA gained by the crossover must be less than I'5 × Io e mol. wt. since no other unique fragment is present.
In summary, the results obtained with all five enzymes indicate that four recombinational events have occurred. The minimum boundaries of the crossover sites appear to be: (i) between the HSV-2 EcoRI J, ! and HSV-I Hsu[ J, A cleavage sites; (ii) between the HSV-I HpaI, V and HSV-2 HpaI H, D cleavage sites; (iii) the boundaries of this crossover are difficult to define but must come to the right of the HSV-2 HsuI E, A cleavage site to a point 0"57 on HSV-I ; (iv) as for (iii) from HSV-I at 0"57 to a point before Bglll C, N. Fig. 2 shows the map positions of the crossover regions. Fig. 3 shows the results of the restriction endonuclease analysis of the intertypic recombinants isolated in this study which have both HSV-I and HSV-2 sequences in their genomes. Of the 23 putative recombinants isolated, four (RSI 0, RSI 1, RSI2 and RSI4) have identical restriction endonuclease maps (with the five enzymes used) to that of the DNA of HSV-I and five (RBz0, RB25, RB51, RB53 and. RB74) have maps identical to that of the DNA of HSV-2. Fig. 4 shows the restriction endonuclease maps of the other recombinants used in this study (Morse et al. i977) .
Summation of recombinant analyses

Mapping of the thymidine kinase genes of HSV-I and HSV-2
The recombinants RSIo, RSI 1, RSI2, RSI 4, RB23, RB28, RB29, RB210, RB211, C4D, C5D and C6D unambiguously specify type I thymidine kinase (Table 6 ). From the restriction endonuclease analyses of these recombinants ( Fig. 3 and 4 ) the only region of type I DNA common to these viruses is that between o'3o0 and o'385. The structural gene for type I thymidine kinase therefore lies in this region. The limits of the gene position can be narrowed if we take into account the recombinants which fail to specify type I or type 2 thymidine kinase by any criterion. Thus RB5o and RB5~ are TK -, the type ~ parent, ts LBs, being TK- (Table 3 ) whereas the type 2 parent, 3345, is TK + (Table 4) ; RB70, RB71, RB73, RB75, RB76 and RB77 are TK-, the type ~ parent ts LB7, being TK- (Table 3) , the type 2 parent being 3345; D3Et, D4E2, D4E3, D5EI and D5E2 are TK-, the type I parental strain, ts E6, being TK- (Aron et al. I973) whereas the type 2 parental strain, ts B5, is TK +. In each case, therefore, the type I parental strain is TK -, the type 2 parental strain is TK +. It is probable, therefore, that these recombinants have gained a mutated thymidine kinase gene from the type i parental strain in every case. The only region of type I DNA common to all of these recombinants and to the recombinants specifying type I thymidine kinase is that between o'300 and 0"309 which, therefore, contains the type I thymidine kinase structural gene. None of the recombinants specifying type 2 thymidine kinase possess this region of type t DNA.
The recombinants RB20, RB25, RB51, RB53, RB74, A8E, CID, C2D, DIE4 and DIE5 unambiguously specify type 2 thymidine kinase and RSI z specifies type 2 thymidine kinase detectable by gel diffusion though not by enzyme activity. Reference to Fig. 3 and 4 reveals that these recombinants possess three regions of type 2 DNA in common, namely o to o-I67, 0.295 to o.4IO and o'7o5 to I. Other recombinants, however, possess some of these regions of type 2 DNA but do not specify type 2 thymidine kinase. For example RB50, C4D and C5D each possess type 2 DNA from o to o.21 but do not specify type 2 thymidine kinase, thus eliminating the region o to o'I67. RB29, C5D, C6D and D5E2 each possess type 2 DNA from 0"695 to t but do not specify type 2 thymidine kinase thus eliminating the region o.7o 5 to I. The region possessing the type 2 thymidine kinase gene is therefore 0.295 to o'4~o. By considering recombinants RB50, RB7o, RB7~ and RB7~ in the same way, the boundaries of the type 2 thymidine kinase gene are narrowed to o-295 to o'3 I5. Type I and type 2 thymidine kinase structural genes are therefore co-linear. DNA of these recombinants with restriction endonucleases has shown that 14 of the 23 contain both HSV-r and HSV-2 sequences in their genomes (Fig. 3) . Of the remaining nine recombinants, RSIo, RS]I, RSI2 and RSI 4 have restriction endonuclease maps (with the five enzymes tested) identical to that of HSV-r and RB20, RB25, RB51, RB5a and RB74 have restriction endonuclease maps identical to that of HSV-2. These viruses are therefore either revertants of the type I parental ts mutant or true recombinants with crossovers involving very short heterologous DNA sequences. That such crossovers do occur is evident from the analysis of, for example, RB28, RB211, and RB50 in which some crossovers are detected not because of the appearance of a unique DNA fragment but because in order to explain the restriction endonuclease data one either has to conclude a double crossover picking up a cleavage site (e.g. o'4 map unit on type 2 DNA with RB2s and RB211 ) or one avoiding an expected cleavage site (e.g. RB50, o'57 map unit on type 2 DNA with HpaI digest; Fig. 2 ). In addition, RB2o, RB25 and RB74 are neutralized by both type T-and type 2-specific antiserum and, therefore, possess HSV-I-and HSV-2-specific antigenic sites involved in neutralization. These three viruses also specify type i-specific as well as mainly type 2-specific polypeptides and, therefore, clearly seem to be recombinant viruses with crossovers involving very short regions of type I DNA (I. W. Halliburton, unpublished data (I977), I3 recombinants were found to be TK-by assay of enzyme activity. In most cases this correlated with ability to grow in the presence of BrdUrd (Table 5 ) but for three of these viruses, D3EI, D4E2 and D4E3, the yield obtained in the presence of BrdUrd was appreciably less than that expected. For D4E2 a crossover does occur very close to the type x thymidine kinase gene and may have affected its response to BrdUrd. In addition, RB5~ was able to grow to a greater extent than expected in the presence of BrdUrd, although it does specify low but reproducibly detectable levels of thymidine kinase. The ability to grow to a certain extent in the presence of BrdUrd does not necessarily correlate with the low levels of thymidine kinase induced since C4D induces comparable levels of enzyme activity yet fails to grow in the presence of BrdUrd (Table 5) .
RSI3 is of particular interest since although no thymidine kinase is detectable by assay of enzyme activity and the virus grows in the presence of BrdUrd, therefore, showing the recombinant to be TK-, thymidine kinase is detectable serologically by gel diffusion with type 2 thymidine kinase antiserum. A crossover does occur very close to the type 2 thymidine kinase gene and this may have affected the activity of the type 2 enzyme but not its antigenicity.
The thymidine kinase induced by the remaining 22 recombinants was typed by thermolability of enzyme activity, neutralization with type I or type 2 antiserum and gel diffusion with type I or type 2 thymidine kinase antiserum (Table 6 ). The results by each approach were totally consistent for all recombinants with the possible one exception of thermolability of enzyrne activity for C4D. This enzyme was clearly typed as type t by neutralization and by gel diffusion but exhibited rather more thermolability than any of the other type I thymidine kinases. It is of interest that this recombinant also has a crossover close to the type I thymidine kinase gene which may have partially affected the thermolability of the enzyme activity.
Correlation of the typing of thymidine kinase induced by the recombinants with the restriction endonuclease analysis of their DNAs allowed independent mapping of the type t and type 2 genes specifying the enzymes. The type I thymidine kinase gene maps between o'3oo and o-3o9 map unit, the type z gene between 0.295 and 0"3 I5. The type t map location represents enough DNA to code for a protein of approx. 99ooo tool. wt., more than enough for a thymidine kinase monomer of 44000 tool. wt. (Honess & Watson, I974b ) .
So far, the only reported functions located on the physical map are the virus thymidine kinase and functions affecting inhibition of host protein and DNA synthesis (Fenwick et al. 1979 (I978) , from an analysis of a small number of intertypic recombinants, suggested that the type I thymidine kinase gene mapped between 0.27 and o'35 map unit. They used only three TK-recombinants isolated from crosses involving a TK -type I and TK + type 2 parental virus. In addition, Morse et al. 0978) from analysis of the polypeptides specified by intertypic recombinants have mapped 1CP 35 (tool. wt. 42ooo) between o'27 and o'35 map unit. This is of interest since the tool. wt. of HSV-I thymidine kin ase has been shown to be 43 ooo to 44 ooo (Honess & Watson, i974b; Courtney et al. I976) . Thymidine kinase and ICP 35 may, therefore, be one and the same.
There is only one published report involving physical mapping of HSV-2 thymidine kinase. [After submission of this paper, Minson et al. 0979) showed that the HSV-2 thymidine kinase gene lies at approx. 0"3 map unit by identification of the DNA sequences carried by two cell lines which had been transformed to a TK phenotype with HSV-2 DNA. Their determination of the map position of the HSV-2 thymidine kinase gene is therefore in agreement with that of this paper.] Maitland & McDougall (I977) found an HSV-2 DNA fragment able to transform LM TK-cells to a TK + phenotype, the transformants specifying a thymidine kinase identical to that of HSV-2 as judged by thermolability and mobility on PAGE. The transforming fragments were judged to lie between o'532 and o'646 map unit, limits which also assign the map location to the thymidine kinase gene on the HSV-2 genome.
The Maitland & McDougall (I977) . Two pieces of data in this report argue against the map location found by Maitland & McDougall (1977) : first, the recombinant C5D possesses type 2 DNA from 0.532 to o'646 yet induces a type t thymidine kinase in lytic infection and second, the recombinants A8E, DIE4 and D~E5 lack type 2 DNA from o'532 to o'646 yet induce a type 2 thymidine kinase in lytic infection. From the wide and extensive interchange of genomic regions throughout type I and type 2 found in intertypic recombinants, it seems necessary that the linear order of genes of HSV-I and HSV-2 must be at least grossly the same. It would, therefore, be surprising if the thymidine kinase gene of HSV-2 was some 23 to 34 map units to the right of that of HSV-I as the data of Maitland & McDougall (I977) for type z thymidine kinase would suggest, in comparison with all available mapping data for type I thymidine kinase. Moreover, it is of interest that of the 36 recombinants studied in this report, none specifies both a type I and a type 2 thymidine kinase. The thymidine kinase genes of HSV-I and HSV-2 are, therefore, co-linear.
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